Evidence map›Paper›PMID 34684701›Full record

ArticleMolecules (Basel, Switzerland)2021

The Amyloid Fibril-Forming β-Sheet Regions of Amyloid β and α-Synuclein Preferentially Interact with the Molecular Chaperone 14-3-3ζ.

Danielle M Williams, David C Thorn, Christopher M Dobson, Sarah Meehan, Sophie E Jackson, Joanna M Woodcock, John A Carver

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Protein Interactome of Amyloid-β as a Therapeutic Target.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Danielle M WilliamsDepartment of Chemistry, School of Physical Sciences, The University of Adelaide, Adelaide, SA 5001, Australia.
David C ThornResearch School of Chemistry, The Australian National University, Acton, ACT 2601, Australia.ORCID 0000-0002-7332-2292
Christopher M DobsonYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
Sarah MeehanYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.ORCID 0000-0002-2778-4373
Sophie E JacksonYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
Joanna M WoodcockCentre for Cancer Biology (An Alliance between SA Pathology and the University of South Australia), Adelaide, SA 5000, Australia.ORCID 0000-0001-5127-9687
John A CarverResearch School of Chemistry, The Australian National University, Acton, ACT 2601, Australia.ORCID 0000-0002-2441-8108

Funding

National Health and Medical Research Council 1068087
6 · The paper itself

Abstract

14-3-3 proteins are abundant, intramolecular proteins that play a pivotal role in cellular signal transduction by interacting with phosphorylated ligands. In addition, they are molecular chaperones that prevent protein unfolding and aggregation under cellular stress conditions in a similar manner to the unrelated small heat-shock proteins. In vivo, amyloid β (Aβ) and α-synuclein (α-syn) form amyloid fibrils in Alzheimer's and Parkinson's diseases, respectively, a process that is intimately linked to the diseases' progression. The 14-3-3ζ isoform potently inhibited in vitro fibril formation of the 40-amino acid form of Aβ (Aβ

Indexed as

14-3-3 Proteinsalpha-SynucleinAmyloidAmyloid beta-PeptidesHumansMolecular ChaperonesProtein AggregatesProtein BindingProtein ConformationProtein Conformation, beta-StrandProtein Interaction Domains and MotifsProtein Unfolding14-3-3 Proteinsalpha-SynucleinAmyloidAmyloid beta-PeptidesMolecular ChaperonesProtein Aggregates14-3-3 proteinsamyloid fibrilamyloid βmolecular chaperoneNMR spectroscopyα-synuclein

Identifiers

PMID34684701
PMCPMC8538830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.